Today's Daily Dose brings you news about the stellar financial results of InMode, the notice of delisting received by Option Care Health, FDA clearance of the first-ever rapid Chlamydia and Gonorrhea (CT/NG) test, and rosy outlook of Personalis.
from RTT - Biotech https://ift.tt/300p1z5
via IFTTT
No comments:
Post a Comment